Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 19, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	334,354	170,528	81,683	-	-
Market Cap Growth	124.88%	108.77%	-	-	-
Enterprise Value	378,134	209,922	130,128	-	-
Last Close Price	252.60	128.81	66.78	-	-
PE Ratio	737.60	956.95	-	-	-
PS Ratio	3.49	2.09	1.15	-	-
PB Ratio	3.84	2.16	1.21	-	-
P/TBV Ratio	8.14	4.71	3.51	-	-
P/FCF Ratio	-	58.30	-	-	-
P/OCF Ratio	44.58	16.98	16.88	-	-
EV/Sales Ratio	4.34	2.57	1.84	-	-
EV/EBITDA Ratio	27.19	18.43	22.58	-	-
EV/EBIT Ratio	57.71	45.62	-	-	-
EV/FCF Ratio	-1218.21	71.77	-	-	-
Debt / Equity Ratio	0.61	0.60	0.83	0.62	0.54
Debt / EBITDA Ratio	3.61	4.00	9.21	3.63	2.30
Debt / FCF Ratio	-	16.10	-	-	-
Asset Turnover	0.58	0.55	0.52	0.57	-
Inventory Turnover	1.54	1.69	1.94	1.87	-
Quick Ratio	0.43	0.61	0.64	0.69	0.82
Current Ratio	1.03	1.25	1.26	1.34	1.47
Return on Equity (ROE)	0.58%	0.24%	-2.77%	6.11%	-
Return on Assets (ROA)	2.46%	1.93%	-0.20%	2.96%	-
Return on Capital (ROIC)	2.95%	2.30%	-0.24%	3.60%	-
Earnings Yield	0.14%	0.10%	-2.28%	-	-
FCF Yield	-0.10%	1.72%	-5.89%	-	-
Dividend Yield	0.04%	0.09%	-	-	-
Payout Ratio	0.00%	-	-	13.30%	-
Buyback Yield / Dilution	-9.21%	-7.85%	-0.95%	-87.83%	-
Total Shareholder Return	-9.17%	-7.76%	-0.95%	-87.83%	-

Source: S&P Capital IQ. Standard template. Financial Sources.